During the past decade, The MetroHealth System (Pregnancy Cohort) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The MetroHealth System (Pregnancy Cohort)" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The MetroHealth System (Pregnancy Cohort)" are "SARS-CoV-2 Infection" (1 trials) and "SARS-CoV2 Infection" (1 trials). Many other conditions were trialed in "The MetroHealth System (Pregnancy Cohort)" in a lesser frequency.

The vast majority of trials in "The MetroHealth System (Pregnancy Cohort)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The MetroHealth System (Pregnancy Cohort)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The MetroHealth System (Pregnancy Cohort), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The MetroHealth System (Pregnancy Cohort), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".